Psyence Biomedical Ltd. (PBMWW) stock
PBMWWNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBM
$0.01−0.00 (-2.50%)
Close on Oct 30, 2026Market cap –P/E –Yield –
Psyence Biomedical total assets
Total assets on the balance sheet at the end of each period.
Psyence Biomedical's total assets was $17.57M at Mar 31, 2026. For fiscal 2026 it was $17.57M, up 140.1% from the year before. The highest annual figure on record is $17.57M in fiscal 2026.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $17.57M | +140.1% |
| FY2025 | Mar 31, 2025 | $7.32M | +546.2% |
| FY2024 | Mar 31, 2024 | $1.13M | -28.8% |
| FY2023 | Mar 31, 2023 | $1.59M | -13.1% |
| FY2022 | Mar 31, 2022 | $1.83M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026 | Mar 31, 2026 | $17.57M | +1451.7% |
| Q2 FY2026 | Sep 30, 2025 | $12.81M | +705.5% |
| Q4 FY2025 | Mar 31, 2025 | $7.32M | +299.7% |
| Q2 FY2025 | Sep 30, 2024 | $2.25M | – |
| Q4 FY2024 | Mar 31, 2024 | $1.13M | – |
| Q4 FY2023 | Mar 31, 2023 | $1.59M | – |
| Q4 FY2022 | Mar 31, 2022 | $1.83M | – |